Tibial muscular dystrophy is a rare genetic muscle condition that mainly weakens the lower legs. People with tibial muscular dystrophy often notice trouble lifting the front of the foot, leg cramps, and frequent tripping in mid to late adulthood. The condition usually progresses slowly over many years and most people remain mobile, though they may need braces or a cane later. Life expectancy is generally near typical, but daily activities can be limited by leg weakness. Treatment focuses on exercise tailored by a physical therapist, ankle–foot orthoses, fall prevention, and pain or cramp management.
Overview
Tibial muscular dystrophySymptoms
Tibial muscular dystrophy begins in adulthood with weakness in the front of the lower legs, causing foot drop, tripping, and trouble walking on heels or climbing stairs. Calf cramps may occur. It progresses slowly and usually spares heart and breathing.
Outlook and prognosis
Most people with tibial muscular dystrophy notice slowly progressive weakness in the lower legs and feet, often starting in mid‑ to later adulthood. Walking and balance changes usually evolve over decades, and many remain independent. Regular exercise, ankle support, and fall‑prevention help maintain mobility.
Causes and risk factors
Tibial muscular dystrophy is usually caused by a TTN (titin) gene mutation, most often inherited in an autosomal dominant pattern. Risk rises with a first-degree relative and Finnish ancestry. Age-related onset is typical; lifestyle and environment don’t cause it.
Genetic influences
Genetics are central in tibial muscular dystrophy. Most cases result from inherited changes in the TTN gene, typically passed in an autosomal dominant pattern. Family history strongly guides risk, but genetic testing confirms the diagnosis and helps with counseling.
Diagnosis
Doctors consider characteristic lower‑leg weakness patterns and family history, then use tests to confirm. Electromyography, muscle MRI, and sometimes biopsy support the diagnosis, while TTN genetic testing provides confirmation. Genetic diagnosis of Tibial muscular dystrophy is now standard.
Treatment and drugs
Treatment for tibial muscular dystrophy focuses on staying mobile, protecting joints, and managing foot drop and fatigue. Care often includes physiotherapy, ankle–foot orthoses, tailored exercise, pain control, and fall-prevention. Regular follow-ups monitor strength, walking safety, and heart or breathing health.
Symptoms
Walking on uneven ground can start to feel less sure, with toes catching or a foot that tires quickly. Early symptoms of tibial muscular dystrophy often include trouble lifting the front of the foot, making heel-walking or quick steps harder. Symptoms vary from person to person and can change over time. The condition usually progresses slowly over years, and many people stay active by pacing activities or using simple supports.
The front of the foot doesn’t lift as strongly, so the toes may drag or catch on the ground. You may notice a higher step to clear the toes or a slapping sound when the foot lands.
Lifting the big toe becomes hard, especially when walking fast or uphill. This can make heel-walking difficult and may show up before other leg weakness.
Toes catching on carpets, curbs, or uneven paths leads to more frequent stumbles. Falls can happen, especially when tired or distracted.
The muscles along the front of the lower leg tire quickly with walking or standing. You may need more breaks on longer walks or after a busy day.
How people usually first notice Tibial muscular dystrophy?
Many people first notice tibial muscular dystrophy in mid- to late adulthood when the muscles along the front of the lower legs start to weaken, making it harder to lift the foot while walking (foot drop) or to climb stairs without tripping. Families sometimes recognize a pattern—relatives who developed similar lower-leg weakness or needed ankle-foot supports—so the “first signs of tibial muscular dystrophy” may be a familiar story that repeats across generations. Doctors often confirm how tibial muscular dystrophy is first noticed by examining weakness limited mainly to the tibialis anterior muscles, checking nerve and muscle studies, and, when appropriate, ordering genetic testing for the common Finnish TMD mutation in the TTN gene.
Types of Tibial muscular dystrophy
Tibial muscular dystrophy has a few recognized clinical variants linked to changes in the TTN gene, which affect the titin protein in muscle. People with the classic form often notice weakness in the front of the lower legs first, usually later in adulthood. Symptoms don’t always look the same for everyone. When reading about types of Tibial muscular dystrophy, you’ll see that the age symptoms start and how quickly they progress can differ by variant.
Late‑onset TMD
Weakness begins in the tibialis anterior muscle, making it harder to lift the front of the foot. This usually starts after age 35–40 and progresses slowly, often staying limited to the lower legs for many years.
Early‑onset TMD
Similar muscles are affected but symptoms appear earlier in adulthood. People may notice foot drop sooner and may develop calf thinning at a younger age.
Proximal‑involving TMD
Weakness starts in the lower legs but later includes muscles closer to the hips and thighs. Walking long distances or climbing stairs may become harder over time.
Scandinavian founder type
A well‑described TTN change found more often in people with Finnish or nearby Northern European ancestry. Symptoms mirror late‑onset TMD with very slow progression and mainly lower‑leg involvement.
TTN mutation spectrum
Different TTN changes can shift which muscles are involved and when symptoms start. Having one type doesn’t necessarily mean you’ll develop the others.
What genetics can tell you about symptoms
Some people with tibial muscular dystrophy who carry TTN gene changes first notice weakness in the shin muscles, causing foot drop and tripping in mid to late adulthood. Specific TTN variants can also bring mild calf wasting and trouble standing on heels, while heart and breathing muscles are usually spared.
Causes and risk factors
Tibial muscular dystrophy is most often caused by a change in the TTN gene. Some risks are written in our DNA, passed down through families. The main risk factors for tibial muscular dystrophy are having an affected parent and Finnish ancestry. Symptoms usually appear in adulthood, and age can influence when weakness starts. Lifestyle does not cause the condition, but heavy long-term muscle strain may affect how fast weakness progresses.
Environmental and biological risk factors
Tibial muscular dystrophy (TMD) is largely driven by internal, body-based factors present from conception. Some risks are carried inside the body, others come from the world around us. For this condition, biological influences matter more, and specific environmental risk factors for tibial muscular dystrophy have not been proven.
Tibial muscular dystrophy is more common among people with Finnish or nearby Northern European roots. In these populations, the baseline likelihood of developing TMD is higher than in most other groups.
As men age, new changes arise more often in sperm and can, rarely, lead to a first case starting in a family. This makes the chance of a brand-new case of tibial muscular dystrophy slightly higher for children of older fathers.
No specific toxins, infections, or pregnancy exposures have been shown to raise the chance of tibial muscular dystrophy. Current research does not link air pollution, heavy metals, radiation, or common chemicals to a higher risk of TMD.
Genetic risk factors
In tibial muscular dystrophy, most cases come from changes in the TTN gene, which provides instructions for a large muscle protein called titin. Carrying a genetic change doesn’t guarantee the condition will appear. It typically follows an autosomal dominant pattern, meaning one altered copy can be enough to increase risk, with symptoms often beginning in mid-adulthood. Genetic testing can confirm the exact TTN change and help clarify who in a family may be at risk.
TTN gene variants: Changes in the TTN gene are the primary cause of tibial muscular dystrophy. These changes affect a large muscle protein called titin and mainly involve the far end of the gene.
Autosomal dominant pattern: Inheriting one altered copy from either parent can cause tibial muscular dystrophy. Each child of an affected parent has a 50% chance of inheriting the variant.
Family history: Having a parent, sibling, or child with tibial muscular dystrophy raises the chance you carry the same TTN change. Relatives without symptoms may still carry the variant due to age-related onset.
Age-related penetrance: Many carriers stay symptom-free until midlife, with onset often after age 35–50. This delayed effect can make family patterns hard to spot. Recognizing early symptoms of tibial muscular dystrophy in midlife can prompt timely testing.
Finnish founder variant: A specific TTN change is more common in people with Finnish ancestry, due to a founder effect. Similar changes can appear in other populations as well.
Variable expressivity: The same TTN change can lead to milder or more pronounced weakness among relatives. Differences in age at onset and speed of progression are common.
Genetic testing confirmation: Finding a disease-causing TTN variant on testing strongly supports a diagnosis of tibial muscular dystrophy and identifies at-risk relatives. Targeted testing for a known family variant is the most informative approach.
New TTN change: Most people inherit the variant from an affected parent, but a change can arise for the first time in a family. In these cases, siblings are usually at low risk but future children can inherit it.
Distal titin region: Changes near the far end of the TTN gene tend to cause tibial muscular dystrophy rather than heart problems. Variants in other TTN regions can lead to different titin-related conditions.
Lifestyle risk factors
Tibial muscular dystrophy is a genetic condition; lifestyle habits do not cause it, but they can shape symptom control, mobility, and complication risks. In practice, how lifestyle affects Tibial muscular dystrophy centers on preserving muscle function, protecting joints, and preventing falls. Below are lifestyle risk factors for Tibial muscular dystrophy that can worsen symptoms or, when optimized, help maintain function.
Regular, low‑impact strength and balance training can help maintain ankle stability and reduce foot‑drop–related tripping. High‑load or eccentric activities like sprinting, jumping, or downhill running can increase muscle strain and fall risk. Pacing workouts with rest days may limit prolonged post‑exercise weakness.
Excess body weight increases torque at the ankle and foot, accelerating fatigue and making foot‑drop more disabling. Modest weight loss can lower the energy cost of walking and delay reliance on assistive devices.
Supportive shoes with firm heel counters and good toe clearance reduce tripping and micro‑injuries in weak tibial muscles. Minimalist or unsupportive footwear can worsen foot‑drop mechanics and increase falls on uneven ground.
Overexertion can trigger prolonged weakness and overuse pain in already compromised distal muscles. Planned rest, task prioritization, and breaking activities into shorter bouts can help preserve function through the day.
Risk prevention
Tibial muscular dystrophy is genetic, so you can’t prevent the condition itself, but you can lower the chances of falls and slow day-to-day impact on mobility. Prevention is about lowering risk, not eliminating it completely. Recognizing early symptoms of Tibial muscular dystrophy—like frequent tripping, ankle weakness, or foot slapping—can prompt earlier support and safer habits. Regular, tailored care helps protect strength, balance, and independence over time.
See a neuromuscular clinic regularly to track strength, gait, and ankle motion. Spotting small changes early allows timely therapy, bracing, or home safety tweaks.
Focus on low-impact strength, balance work, and gentle range-of-motion. Avoid high-load or repetitive downhill and stair workouts that overstrain the front-of-leg muscles.
Make home paths clear, add grab bars, and use good-grip shoes. Small layout changes cut tripping risk when foot lift is weak.
Ankle-foot orthoses can support foot drop and improve walking efficiency in Tibial muscular dystrophy. They can also lower fatigue and reduce falls during longer walks.
Transmission
Tibial muscular dystrophy is not contagious; you can’t catch it from someone else through everyday contact, coughing, or bodily fluids. Instead, tibial muscular dystrophy results from a genetic change passed in an autosomal dominant way—if a parent has the condition, each child has a 50% chance of inheriting the altered gene.
Occasionally, tibial muscular dystrophy appears for the first time in a family because of a new genetic change, so the parents are typically unaffected. If you have questions about how tibial muscular dystrophy is inherited or the genetic transmission of tibial muscular dystrophy in your family, a genetics professional can review your family history and discuss testing for at-risk relatives.
When to test your genes
Consider genetic testing if you have progressive weakness in the feet or ankles, a family history of Tibial muscular dystrophy, or a known mutation in a close relative. Testing can confirm the diagnosis, guide monitoring and physical therapy, and inform anesthesia and medication choices. A genetics professional can help you decide timing and insurance coverage.
Diagnosis
Many living with Tibial muscular dystrophy first notice everyday things getting harder—like lifting the front of the foot when walking, tripping on curbs, or tiring on stairs. Doctors usually begin with a careful exam and questions about when symptoms started and how they affect walking and balance. Because this condition often has telltale patterns in the lower legs, the diagnosis of Tibial muscular dystrophy is confirmed with specific tests. Genetic testing can provide clarity, and imaging or muscle biopsy may be used when results are unclear.
The pattern typically shows weakness in the muscles that lift the foot and toes, while calf strength may be relatively preserved at first. Your clinician will check walking, toe and heel rises, and ankle flexibility. Subtle findings like foot-slap or frequent tripping can be early clues.
A detailed family and health history can help map who else may have similar symptoms and the age they began. This supports whether the condition may be inherited in a dominant pattern. It also guides who in the family might benefit from evaluation.
A simple blood test checks muscle enzymes, which are often normal or only mildly raised in Tibial muscular dystrophy. A high result suggests more active muscle injury and may point to other causes. Normal results do not rule out this diagnosis.
EMG looks at muscle electrical activity and often shows a myopathic pattern consistent with muscle disease rather than nerve damage. Nerve conduction studies are usually normal, helping distinguish it from neuropathy. These tests can guide which muscle to sample if a biopsy is needed.
Stages of Tibial muscular dystrophy
Tibial muscular dystrophy does not have defined progression stages. It usually advances very slowly over many years and mainly involves the muscles that lift the front of the foot, with the timing and pace varying widely between people. Early and accurate diagnosis helps you plan ahead with confidence. Doctors usually start with a conversation about symptoms and family history, then examine ankle and toe-lift strength; tests such as electromyography, blood creatine kinase, muscle imaging, and genetic testing for TTN changes can confirm the cause and track changes in walking and balance over time, and clinicians often look for early symptoms of tibial muscular dystrophy such as subtle tripping or foot drop.
Outlook and prognosis
Daily life with tibial muscular dystrophy often centers on managing leg weakness, tripping less, and pacing activities so you can keep working, walking, and doing the things you enjoy. Many people ask, “What does this mean for my future?”, and the short answer is that TMD usually progresses slowly over decades, mainly affecting the muscles in the front of the lower legs. Most people with tibial muscular dystrophy keep their independence for a long time, and the condition by itself is not linked to a shorter life span. Some notice foot drop and fatigue first, while others don’t have clear early symptoms of tibial muscular dystrophy until mid‑ to later adulthood. When thinking about the future, it helps to know that the heart and breathing muscles are typically not involved in TMD, which is one reason survival is near normal for most.
The outlook is not the same for everyone, but most people experience a gradual, stepwise change rather than sudden loss of function. Falls and ankle sprains are common risks as foot lift weakens; simple supports like ankle‑foot orthoses, balance exercises, and safe-home setups often cut that risk. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. If TMD runs in your family, relatives may show different ages of onset and different speeds of progression, even with the same gene change. There are no medicines that reverse muscle loss yet, but focused strength and flexibility programs, energy‑saving strategies, and fall‑prevention plans can preserve mobility and confidence for many years.
Talk with your doctor about what your personal outlook might look like. Looking at the long-term picture can be helpful, especially if you’re planning work, caregiving, travel, or future home modifications. With ongoing care, many people maintain active routines and adapt to changes with practical tools rather than major limitations. If new symptoms appear—such as sudden worsening weakness, numbness, or breathing concerns—ask about early warning signs and what steps to take if they appear, since not all changes are due to tibial muscular dystrophy itself. Genetic testing can sometimes provide more insight into prognosis, and not everyone with the same gene change will have the same outlook.
Long-term effects
Over time, daily routines may shift as ankle weakness makes walking on uneven ground or climbing stairs harder. Tibial muscular dystrophy usually worsens slowly over many years, and many people remain mobile and independent. Long-term effects vary widely, and most do not involve the heart or lungs. Life expectancy is generally similar to the broader population.
Weakness in the muscles that lift the front of the foot can lead to foot drop. This often causes catching the toes and more frequent stumbles on curbs or uneven ground. Walking may feel safer with shorter steps.
Changes typically build slowly over 10–30 years. Many people with tibial muscular dystrophy keep walking into later adulthood. The pace of change can differ even within the same family.
Early symptoms of tibial muscular dystrophy often center on the front of the lower leg. Climbing stairs, jogging, or lifting the toes while driving may become harder. Daily walking on hills can feel more tiring.
As foot control decreases, balance can feel less steady. Uneven surfaces, gravel, or wet floors may raise the risk of slips. Some may notice more caution with night-time walking.
How is it to live with Tibial muscular dystrophy?
Day to day, tibial muscular dystrophy often starts as a subtle change—tripping more on uneven ground, feeling ankle weakness after a short walk, or needing a handrail on stairs—and gradually becomes a steady companion to plan around. Many people adapt by choosing supportive shoes or ankle–foot orthoses, pacing activities, and prioritizing fall prevention, while keeping up with physical therapy to maintain balance and mobility. Work, family life, and hobbies may shift toward lower-impact options, and loved ones often become partners in small adjustments—offering a steady arm on curbs, arranging seating breaks, or helping with tasks that require prolonged standing. With thoughtful planning and the right supports, many continue to stay active and independent, focusing on what they can do safely rather than what they can’t.
Treatment and drugs
Treatment for tibial muscular dystrophy focuses on easing symptoms, protecting mobility, and maintaining independence over time. There’s no cure yet, so care usually includes physical therapy to keep ankle strength and flexibility, bracing (such as ankle–foot orthoses) to steady the foot and reduce tripping, and targeted exercises to support balance and walking. Pain from overuse or cramps can be managed with nonprescription pain relievers, heat, stretching, and pacing activities; a physiotherapist can help set safe limits to avoid muscle strain. Supportive care can make a real difference in how you feel day to day, and many people with tibial muscular dystrophy remain active with the right adjustments. Ask your doctor about the best starting point for you, including referrals to neuromuscular clinics, fall-prevention strategies, and when to consider mobility aids to stay safe and engaged in daily life.
Non-drug treatment
Tibial muscular dystrophy mainly weakens the muscles that lift the foot, so day-to-day goals focus on steadier walking, fewer stumbles, and staying active without overdoing it. Non-drug treatments often lay the foundation for safer movement and maintaining independence. Plans are tailored to the person, since strength, balance, and fatigue can vary. Small, consistent steps usually work better than big changes that are hard to keep up.
A tailored program helps maintain strength, balance, and joint motion while protecting tired muscles. Therapists teach safe ways to move and avoid falls.
Gentle, regular exercises focus on the muscles around the ankle and lower leg without overstraining them. Your plan may include low-impact options like cycling or water-based exercise.
Light ankle-foot orthoses can lift the toes to reduce tripping and support a smoother step. They can be worn in regular shoes and adjusted as needs change.
Training improves stride, turns, and obstacle navigation to reduce falls. Practice may include treadmill support, step strategies, and dual-task walking.
Your genes may have an impact on how drugs work for you
Medications for tibial muscular dystrophy can work differently from person to person because gene variants affect how drugs are absorbed, broken down, and how muscles respond. Pharmacogenetic testing may guide safer dosing, reduce side effects, and help choose the most effective therapy.
Pharmacological treatments
There’s no cure for tibial muscular dystrophy yet, so medicines focus on easing symptoms like pain, cramps, or nerve‑type discomfort. Drugs that target symptoms directly are called symptomatic treatments. Choices depend on what bothers you most and what other health conditions you have. Finding the right medication can be a process of trial, patience, and adjustment.
These non‑steroidal anti‑inflammatory drugs can relieve activity‑related muscle or joint aches in tibial muscular dystrophy. Use the lowest effective dose and take with food to protect the stomach.
Helpful for pain when anti‑inflammatories aren’t a good fit. Stay within daily limits and avoid extra products containing acetaminophen to protect the liver.
A gel applied to sore areas can ease localized pain with fewer whole‑body side effects. It may help when early symptoms of tibial muscular dystrophy lead to overuse aches around the ankles or shins.
These can calm nerve‑like pain, burning, or tingling if present. Drowsiness and dizziness are common at first, so doses often start low and increase slowly.
Genetic influences
In most families, tibial muscular dystrophy stems from a single inherited change in a muscle gene called TTN (titin), which helps muscle fibers spring back and stay strong. This condition is typically passed down in an autosomal dominant pattern—meaning one changed copy can be enough—and each child of an affected parent has a 1 in 2 (50%) chance of inheriting it. Symptoms often begin in mid- to later adulthood, and even within the same family the age of onset and severity can differ, so some relatives may notice weakness while others remain mildly affected for years. Family history is one of the strongest clues to a genetic influence. Doctors may recommend genetic counseling and genetic testing for tibial muscular dystrophy to confirm the cause, understand your personal risk, and discuss options for relatives. Although it’s especially well described in people with Finnish ancestry, tibial muscular dystrophy can occur in many backgrounds worldwide.
Is Tibial muscular dystrophy genetic?
Genetics are central in tibial muscular dystrophy. Most cases result from inherited changes in the TTN gene, typically passed in an autosomal dominant pattern. Family history strongly guides risk, but genetic testing confirms the diagnosis and helps with counseling.
Pharmacogenetics—how genetics influence drug effects
There isn’t yet a medicine that directly targets the TTN gene change in tibial muscular dystrophy, so care focuses on symptoms and day‑to‑day function; even so, your genes can still shape which supportive drugs work best and which to avoid. Differences in the liver enzymes that process medicines can affect common options such as certain pain relievers, some antidepressants used for chronic pain, and opioids; for example, people who don’t efficiently convert codeine may get little relief, while others may feel stronger‑than‑expected effects at standard doses. Not every difference in response is genetic, but age, kidney and liver health, and other prescriptions also play a role. A well‑studied variant in a transport gene (called SLCO1B1) can raise the chance of statin‑related muscle aches, which matters because new or worsening muscle pain can be hard to tell apart from tibial muscular dystrophy itself. If you ever need a blood thinner—such as after a procedure—genetic differences can guide safer dosing for some drugs like warfarin, helping balance bleeding and clotting risks. Ask your clinician whether pharmacogenetic testing for tibial muscular dystrophy could help personalize your plan, especially if past medicines caused side effects or didn’t help.
Interactions with other conditions
People living with Tibial muscular dystrophy often also manage common conditions of mid‑ to later adulthood, and that mix can shape day‑to‑day function. Doctors call it a “comorbidity” when two conditions occur together. For example, early symptoms of Tibial muscular dystrophy such as foot drop can be mistaken for nerve problems from diabetes or lower‑back issues, which can delay the right support.
Because changes in the TTN gene are also linked to some heart muscle conditions, many clinicians suggest a baseline heart check, especially if there’s a family history of cardiomyopathy, even though most people with Tibial muscular dystrophy never develop heart trouble. Joint arthritis, balance disorders, or peripheral neuropathy can compound leg weakness, making walking, stairs, or uneven ground more challenging. If you take medicines for other health issues—especially drugs that can affect muscles—ask your care team whether any could worsen weakness or cramps and how to monitor for that.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which calves thinned and ankles weakened with age, even when childhood strength seemed normal. A grandparent might have walked briskly for decades, then started tripping on uneven pavement in their 50s. These quiet patterns in everyday life hinted at Tibial muscular dystrophy long before the condition had a name.
First described in the medical literature as a late‑onset weakness of the lower leg muscles in certain Finnish families, it was once considered a local curiosity. As medical science evolved, similar cases were recognized outside Finland, and careful examination showed a consistent pattern: symptoms often began after midlife, toes lifted less easily, and the front of the shin (tibial) muscles gradually lost bulk. Early reports focused on how people walked; later studies added muscle testing, electrical studies, and biopsy findings to create a clearer picture.
In recent decades, knowledge has built on a long tradition of observation. Advances in genetics linked Tibial muscular dystrophy to changes in a gene that helps keep muscle fibers stable. This step confirmed what families had noticed for generations: the condition tends to run in families, usually passing from one affected parent to about half of their children. Recognizing this inheritance pattern helped doctors give more precise counseling and distinguish it from other causes of foot drop in adulthood.
Over time, descriptions became more detailed and more reassuring. Researchers learned that Tibial muscular dystrophy typically progresses slowly and primarily affects the lower legs, with many people staying active and independent for many years. Historical differences highlight why some were misdiagnosed in the past as having nerve problems or different muscle conditions; today, a combination of clinical assessment and genetic testing usually settles the diagnosis.
Current studies build on a long tradition of observation, following large groups over time to understand the range of symptoms and the best ways to support mobility. Looking back helps explain why awareness outside Northern Europe took time to grow, and why early symptoms of Tibial muscular dystrophy were sometimes overlooked. This history now guides earlier recognition, targeted testing, and practical care that focuses on maintaining strength, balance, and confidence in daily life.